Alzeer AH, Fitzgerald JM. Corticosteroids and tuberculosis: risks and use as adjunct therapy. Tubercle and lung disease 1993; 74: 6-11.
Graham SM, Daley HM, Banerjee A, Salaniponi FM, Harries AD. Ethambutol usage in tuberculosis - time to reconsider? Archives of diseases in childhood, 1998, 79: 274-278
Horne NW Modern drug treatment of tuberculosis. 7th edition. London, Chest, Heart and Stroke Association, 1990.
Reider HL. Interventions for tuberculosis control and elimination. Paris, International Union Against Tuberculosis and Lung Disease, 2002.
Stop TB Partnership. Global TB Drug Facility prospectus. Geneva, World Health Organization, 2001 (WHO/CDS/TB/200I.I0a)
World Health Organization. Tuberculosis handbook. Geneva, 1998 (WHO/TB/98.253).
World Health Organization. Guidelines for establishing DOTS-Plus pilot projects for the management of multidrug-resistant tuberculosis. Geneva, 2003 (WHO/CDS/TB/2000.279).
World Health Organization. Treatment of tuberculosis. Guidelines for national programmes. Third edition, Geneva, 2003 (WHO/CDS/TB/2003.313).
World Health Organization, International Union Against Tuberculosis and Lung Disease, Royal Netherlands Tuberculosis Association. Revised international definitions in tuberculosis control. International journal of tuberculosis and lung disease, 2001, 5 (3): 213-215.
Ya Diul M, Maher D, Harries A.Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS, 2001, 15: 143-152.
Was this article helpful?